NCT04081831View on ClinicalTrials.gov

Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer

CompletedOBSERVATIONAL

Enrollment

99,999

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

August 25, 2020

Study Completion Date

August 25, 2020

Conditions

Gastrointestinal Cancer

Interventions

DRUG

Acetylsalicylic Acid (Aspirin, BAYE4465)

Follow clinical administration

Trial Locations (1)

Unknown

University of Hong Kong, Hong Kong

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY